4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000950170-25-094002
Chief Medical Officer sold 1,250 shares at an average $19.17 ($23,962)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Simon Amy Chief Medical Officer | 2025-07-01 | Sale 10b5-1 | −374 | $16.94 | $6,336 | 65,740 | D |
| Simon Amy Chief Medical Officer | 2025-07-03 | Sale 10b5-1 | −876 | $20.12 | $17,625 | 64,864 | D |
| Open-market sales · 1,250 sh · avg $19.17 · $23,962 | |||||||
Loading xslF345X05/ownership.xml…